References
- Ferrari R. Rheumatologic manifestations of renal disease. Curr. Opin. Rheumatol. 1996; 8(1)71–76, [PUBMED], [INFOTRIEVE], [CSA]
- Adams J. E. Dialysis bone disease. Semin. Dial. 2002; 15(4)277–289, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Malluche H. H., Langub M. C., Monier‐Faugere M. C. Pathogenesis and histology of renal osteodystrophy. Osteoporos. Int. 1997; 7(Suppl. 3)184–187
- Adams J. E. Renal bone disease: radiological investigation. Kidney Inter., Suppl. 1999; 73: 38–41, [CROSSREF]
- Eastell R. Treatment of postmenopausal osteoporosis. N. Engl. J. Med. 1998; 338(11)736–746, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Asaka M., Iida H., Entani C., Fujita M., Izumino K., Takata M., Seto H., Sasayama S. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin. Nephrol. 1992; 38(3)149–153, [PUBMED], [INFOTRIEVE]
- Atsumi K., Kushida K., Yamazaki K., Shimizu S., Ohmura A., Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am. J. Kidney Dis. 1999; 33(2)287–293, [PUBMED], [INFOTRIEVE]
- Yamaguchi T., Kanno E., Tsubota J., Shiomi T., Nakai M., Hattori S. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 1996; 19(5)549–555, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Eisenberg B., Tzamaloukas A. H., Murata G. H., Elliott T. M., Jackson J. E. Factors affecting bone mineral density in elderly men receiving chronic in‐center hemodialysis. Clin. Nucl. Med. 1991; 16(1)30–36, [PUBMED], [INFOTRIEVE]
- Fletcher S., Jones R. G., Rayner H. C., Harnden P., Hordon L. D., Aaron J. E., Oldroyd B., Brownjohn A. M., Turney J. H., Smith M. A. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron 1997; 75(4)412–419, [PUBMED], [INFOTRIEVE], [CSA]
- Peretz A., Penaloza A., Mesquita M., Dratwa M., Verhas M., Martin P., de Maertelaer V., Bergmann P. Quantitative ultrasound and dual X‐ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis. Bone 2000; 27(2)287–292, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Canavese C., Barolo S., Gurioli L., Cadario A., Portigliatti M., Isaia G., Thea A., Marangella M., Bongiorno P., Cavagnino A., Peona C., Boero R., D'Amicone M., Cardelli R., Rossi P., Piccoli G. Correlations between bone histopathology and serum biochemistry in uremic patients on chronic hemodialysis. Int. J. Artif. Organs 1998; 21(8)443–450, [PUBMED], [INFOTRIEVE], [CSA]
- Taal M. W., Masud T., Green D., Cassidy M. J. Risk factors for reduced bone density in hemodialysis patients. Nephrol. Dial. Transplant. 1999; 14(8)1922–1928, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Couttenye M. M., D'Haese P. C., Verschoren W. J., Behets G. J., Schrooten I., De Broe M. E. Low bone turnover in patients with renal failure. Kidney Inter., Suppl. 1999; 73: 70–76, [CSA], [CROSSREF]
- Cendoroglo Neto M., Draibe S. A., Silva A. E., Ferraz M. L., Granato C., Pereira C. A., Sesso R. C., Gaspar A. M., Ajzen H. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: evidence for environmental transmission. Nephrol. Dial. Transplant. 1995; 10(2)240–246, [PUBMED], [INFOTRIEVE], [CSA]
- Gordon S. C. Extrahepatic manifestations of hepatitis C. Dig. Dis. 1996; 14(3)157–168, [PUBMED], [INFOTRIEVE]
- Shaker J. L., Reinus W. R., Whyte M. P. Hepatitis C‐associated osteosclerosis: late onset after blood transfusion in an elderly woman. J. Clin. Endocrinol. Metab. 1998; 83(1)93–98, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wakitani S., Hattori T., Nakaya H., Chae Y. M., Murata N., Tanigami A. Clinical images: hepatitis C‐associated osteosclerosis. Arthritis Rheum. 2003; 48(1)268, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Khosla S., Hassoun A. A., Baker B. K., Liu F., Zein N. N., Whyte M. P., Reasner C. A., Nippoldt T. B., Tiegs R. D., Hintz R. L., Conover C. A. Insulin‐like growth factor system abnormalities in hepatitis C‐associated osteosclerosis. Potential insights into increasing bone mass in adults. J. Clin. Invest. 1998; 101(10)2165–2173, [PUBMED], [INFOTRIEVE], [CSA]
- Duarte M. P., Farias M. L., Coelho H. S., Mendonca L. M., Stabnov L. M., do Carmo d Oliveira M., Lamy R. A., Oliveira D. S. Calcium‐parathyroid hormone‐vitamin D axis and metabolic bone disease in chronic viral liver disease. J. Gastroenterol. Hepatol. 2001; 16(9)1022–1027, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Idilman R., de Maria N., Uzunalimoglu O., van Thiel D. H. Hepatic osteodystrophy: a review. Hepatogastroenterology 1997; 44(14)574–581, [PUBMED], [INFOTRIEVE], [CSA]
- Siagris D., Labropoulou‐Karatza C., Christofidou M., Goumenos D., Thomopoulos K., Lekkou A., Gogos C. A., Vlachojannis J. Viraemia, cryoglobulins and autoantibodies in hemodialysis patients infected with hepatitis C virus. Eur. J. Gastroenterol. Hepatol. 2003; 15(2)133–137, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Milotic I., Pavic I., Maleta I., Troselj‐Vukic B., Milotic F. Modified range of alanine aminotransferase is insufficient for screening of hepatitis C virus infection in hemodialysis patients. Scand. J. Urol. Nephrol. 2002; 36(6)447–449, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Khosla S., Ballard F. J., Conover C. A. Use of site‐specific antibodies to chracterize the circulating form of big insulin‐like growth factor II in patients with hepatitis C‐associated osteosclerosis. J. Clin. Endocrinol. Metab. 2002; 87(8)3867–3870, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Beyer H. S., Anderson Q., Shih M. S., Parfitt A. M., Heath H., III. Diffuse osteosclerosis in intravenous drug abusers. Am. J. Med. 1993; 95(6)660–662, [PUBMED], [INFOTRIEVE], [CROSSREF]